
Healthcare biometricsÌýallow users to access applications and patient data quickly - clinicians simply touch a fingerprint scanner and get instant access to the records they need on any workstation.
Highlights
The global Multi-modal Biometrics in Healthcare market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Multi-modal Biometrics in Healthcare is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Multi-modal Biometrics in Healthcare is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Multi-modal Biometrics in Healthcare in Hospitals & Clinics is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Multi-modal Biometrics in Healthcare include BioID AG, IriTech, Inc., M2SYS Technology, NEC Corporation, Safran Group, NEC Corporation, Fujitsu Limited, Suprema Inc. and BIO-key International, Inc(US), etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Multi-modal Biometrics in Healthcare, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multi-modal Biometrics in Healthcare.
The Multi-modal Biometrics in Healthcare market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Multi-modal Biometrics in Healthcare market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multi-modal Biometrics in Healthcare companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
BioID AG
IriTech, Inc.
M2SYS Technology
NEC Corporation
Safran Group
NEC Corporation
Fujitsu Limited
Suprema Inc.
BIO-key International, Inc(US)
HID Global
ASSA ABLOY
ZKteco, Inc.
Segment by Type
Vein Recognition
Voice Recognition
Iris Recognition
Facial Recognition
Fingerprint Recognition
Segment by Application
Hospitals & Clinics
Research & Clinical laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multi-modal Biometrics in Healthcare companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Vein Recognition
1.2.3 Voice Recognition
1.2.4 Iris Recognition
1.2.5 Facial Recognition
1.2.6 Fingerprint Recognition
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals & Clinics
1.3.3 Research & Clinical laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Perspective (2018-2029)
2.2 Multi-modal Biometrics in Healthcare Growth Trends by Region
2.2.1 Global Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Size by Region: 2018 VS 2022 VS 2029
2.2.2 Multi-modal Biometrics in Healthcare Historic Âé¶¹Ô´´ Size by Region (2018-2023)
2.2.3 Multi-modal Biometrics in Healthcare Forecasted Âé¶¹Ô´´ Size by Region (2024-2029)
2.3 Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Dynamics
2.3.1 Multi-modal Biometrics in Healthcare Industry Trends
2.3.2 Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Drivers
2.3.3 Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Challenges
2.3.4 Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multi-modal Biometrics in Healthcare Players by Revenue
3.1.1 Global Top Multi-modal Biometrics in Healthcare Players by Revenue (2018-2023)
3.1.2 Global Multi-modal Biometrics in Healthcare Revenue Âé¶¹Ô´´ Share by Players (2018-2023)
3.2 Global Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multi-modal Biometrics in Healthcare Revenue
3.4 Global Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multi-modal Biometrics in Healthcare Revenue in 2022
3.5 Multi-modal Biometrics in Healthcare Key Players Head office and Area Served
3.6 Key Players Multi-modal Biometrics in Healthcare Product Solution and Service
3.7 Date of Enter into Multi-modal Biometrics in Healthcare Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Multi-modal Biometrics in Healthcare Breakdown Data by Type
4.1 Global Multi-modal Biometrics in Healthcare Historic Âé¶¹Ô´´ Size by Type (2018-2023)
4.2 Global Multi-modal Biometrics in Healthcare Forecasted Âé¶¹Ô´´ Size by Type (2024-2029)
5 Multi-modal Biometrics in Healthcare Breakdown Data by Application
5.1 Global Multi-modal Biometrics in Healthcare Historic Âé¶¹Ô´´ Size by Application (2018-2023)
5.2 Global Multi-modal Biometrics in Healthcare Forecasted Âé¶¹Ô´´ Size by Application (2024-2029)
6 North America
6.1 North America Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Size (2018-2029)
6.2 North America Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Size by Country (2018-2023)
6.4 North America Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Size (2018-2029)
7.2 Europe Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Size by Country (2018-2023)
7.4 Europe Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Size (2018-2029)
8.2 Asia-Pacific Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Size by Region (2018-2023)
8.4 Asia-Pacific Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Size (2018-2029)
9.2 Latin America Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Size by Country (2018-2023)
9.4 Latin America Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Size (2018-2029)
10.2 Middle East & Africa Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Size by Country (2018-2023)
10.4 Middle East & Africa Multi-modal Biometrics in Healthcare Âé¶¹Ô´´ Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioID AG
11.1.1 BioID AG Company Detail
11.1.2 BioID AG Business Overview
11.1.3 BioID AG Multi-modal Biometrics in Healthcare Introduction
11.1.4 BioID AG Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.1.5 BioID AG Recent Development
11.2 IriTech, Inc.
11.2.1 IriTech, Inc. Company Detail
11.2.2 IriTech, Inc. Business Overview
11.2.3 IriTech, Inc. Multi-modal Biometrics in Healthcare Introduction
11.2.4 IriTech, Inc. Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.2.5 IriTech, Inc. Recent Development
11.3 M2SYS Technology
11.3.1 M2SYS Technology Company Detail
11.3.2 M2SYS Technology Business Overview
11.3.3 M2SYS Technology Multi-modal Biometrics in Healthcare Introduction
11.3.4 M2SYS Technology Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.3.5 M2SYS Technology Recent Development
11.4 NEC Corporation
11.4.1 NEC Corporation Company Detail
11.4.2 NEC Corporation Business Overview
11.4.3 NEC Corporation Multi-modal Biometrics in Healthcare Introduction
11.4.4 NEC Corporation Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.4.5 NEC Corporation Recent Development
11.5 Safran Group
11.5.1 Safran Group Company Detail
11.5.2 Safran Group Business Overview
11.5.3 Safran Group Multi-modal Biometrics in Healthcare Introduction
11.5.4 Safran Group Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.5.5 Safran Group Recent Development
11.6 NEC Corporation
11.6.1 NEC Corporation Company Detail
11.6.2 NEC Corporation Business Overview
11.6.3 NEC Corporation Multi-modal Biometrics in Healthcare Introduction
11.6.4 NEC Corporation Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.6.5 NEC Corporation Recent Development
11.7 Fujitsu Limited
11.7.1 Fujitsu Limited Company Detail
11.7.2 Fujitsu Limited Business Overview
11.7.3 Fujitsu Limited Multi-modal Biometrics in Healthcare Introduction
11.7.4 Fujitsu Limited Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.7.5 Fujitsu Limited Recent Development
11.8 Suprema Inc.
11.8.1 Suprema Inc. Company Detail
11.8.2 Suprema Inc. Business Overview
11.8.3 Suprema Inc. Multi-modal Biometrics in Healthcare Introduction
11.8.4 Suprema Inc. Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.8.5 Suprema Inc. Recent Development
11.9 BIO-key International, Inc(US)
11.9.1 BIO-key International, Inc(US) Company Detail
11.9.2 BIO-key International, Inc(US) Business Overview
11.9.3 BIO-key International, Inc(US) Multi-modal Biometrics in Healthcare Introduction
11.9.4 BIO-key International, Inc(US) Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.9.5 BIO-key International, Inc(US) Recent Development
11.10 HID Global
11.10.1 HID Global Company Detail
11.10.2 HID Global Business Overview
11.10.3 HID Global Multi-modal Biometrics in Healthcare Introduction
11.10.4 HID Global Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.10.5 HID Global Recent Development
11.11 ASSA ABLOY
11.11.1 ASSA ABLOY Company Detail
11.11.2 ASSA ABLOY Business Overview
11.11.3 ASSA ABLOY Multi-modal Biometrics in Healthcare Introduction
11.11.4 ASSA ABLOY Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.11.5 ASSA ABLOY Recent Development
11.12 ZKteco, Inc.
11.12.1 ZKteco, Inc. Company Detail
11.12.2 ZKteco, Inc. Business Overview
11.12.3 ZKteco, Inc. Multi-modal Biometrics in Healthcare Introduction
11.12.4 ZKteco, Inc. Revenue in Multi-modal Biometrics in Healthcare Business (2018-2023)
11.12.5 ZKteco, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
BioID AG
IriTech, Inc.
M2SYS Technology
NEC Corporation
Safran Group
NEC Corporation
Fujitsu Limited
Suprema Inc.
BIO-key International, Inc(US)
HID Global
ASSA ABLOY
ZKteco, Inc.
Ìý
Ìý
*If Applicable.
